Search

Author/Creator Friedlander, Michael L.

1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016)

Authors:
Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia Masvidal; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine A.; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy A.;...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4(2016)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 5. Neurophysiological characteristics in the development and recovery of peripheral neuropathy in oxaliplatin and paxlitaxel treated patients. Issue 3 (March 2020)

Authors:
Li, Tiffany; Timmins, Hannah C.; McCrary, J. Matt; Trinh, Terry; Horvath, Lisa G.; Friedlander, Michael L.; Kiernan, Matthew C.; Goldstein, David; Park, Susanna B.
Journal:
Clinical neurophysiology
Issue:
Volume 131:Issue 3(2020:Mar.)
Page Start:
e2
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Benign breast disease increases breast cancer risk independent of underlying familial risk profile: Findings from a Prospective Family Study Cohort. Issue 2 (20th February 2019)

Authors:
Zeinomar, Nur; Phillips, Kelly‐Anne; Daly, Mary B.; Milne, Roger L.; Dite, Gillian S.; MacInnis, Robert J.; Liao, Yuyan; Kehm, Rebecca D.; Knight, Julia A.; Southey, Melissa C.; Chung, Wendy K.; Giles, Graham G.; McLachlan, Sue‐Anne; Friedlander, Michael L.; Weideman, Prue C.; Glendon, Gord; Nesc...
Journal:
International journal of cancer
Issue:
Volume 145:Issue 2(2019)
Page Start:
370
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Development of the Measure of Ovarian Symptoms and Treatment Concerns: Aiming for Optimal Measurement of Patient-Reported Symptom Benefit With Chemotherapy for Symptomatic Ovarian Cancer. Issue 5 (1st June 2014)

Authors:
King, Madeleine T.; Stockler, Martin R.; Butow, Phyllis; O'Connell, Rachel; Voysey, Merryn; Oza, Amit M.; Gillies, Kim; Donovan, Heidi S.; Mercieca-Bebber, Rebecca; Martyn, Julie; Sjoquist, Katrin; Friedlander, Michael L.
Journal:
International journal of gynecological cancer
Issue:
Volume 24:Issue 5(2014)
Page Start:
865
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Factors Associated With Deciding Between Risk-Reducing Salpingo-oophorectomy and Ovarian Cancer Screening Among High-Risk Women Enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group Study. Issue 6 (June 2017)

Authors:
Mai, Phuong L.; Piedmonte, Marion; Han, Paul K.; Moser, Richard P.; Walker, Joan L.; Rodriguez, Gustavo; Boggess, John; Rutherford, Thomas J.; Zivanovic, Oliver; Cohn, David E.; Thigpen, J. Tate; Wenham, Robert M.; Friedlander, Michael L.; Hamilton, Chad A.; Bakkum-Gamez, Jamie; Olawaiye, Alexand...
Journal:
Obstetrical & gynecological survey
Issue:
Volume 72:Issue 6(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗